Despite this, «one 2009 estimate put the number of stem -
cell companies based in China at around 100», says Doug Sipp, a stem - cell ethics and regulation researcher at the RIKEN Center for Developmental Biology in Kobe, Japan.
Not exact matches
• Tessa Therapeutics, a Singapore -
based biopharmaceutical
company focusing on T
cell therapy for solid tumors, raised $ 80 million in funding.
But like many other, overly optimistic hydrogen -
based fuel entrepreneurs, Dean, whose
company made a specialized membrane that was to be used in the fuel -
cell modules, watched the ground open beneath his feet as the commercial take - up proved to be far slower than anyone anticipated.
Perth -
based marine farming
company Cell Aquaculture has cancelled a deal with Noble Rate to buy its Roxy Casino in Cambodia after it failed to source skilled workers and keep up with ongoing reporting procedures.
Bentley -
based information technology
company ISA Technologies has become the first organisation in the southern hemisphere to use revolutionary new IBM
Cell chip technology for high performance computing and visualisation.
The squeeze system Sharei then designed to temporarily disrupt
cell membranes — for which he's been granted most of his 10 patents — is the
basis for SQZ Biotech, the
company he co-founded in 2013 with the pioneering MIT professors he worked for: Klavs Jensen, the school's head of chemical engineering, and Robert Langer, a renowned bioengineer and serial entrepreneur.
• Vineti, a San Francisco -
based cell and gene therapy software and analytics
company, raised $ 13.75 million in Series A funding.
• Luxcel Biosciences, an Ireland -
based company that had developed technology to monitor the growth and viability of
cells for pharmaceutical safety, was acquired by Aglient Technologies, according to The Irish Times.
US -
based pharmaceutical
company Gilead Sciences entered the chimeric antigen receptor (CAR) T -
cell therapy business through its acquisition of Kite Pharma, and Australian biopharma
company CSL Behring acquired US -
based Calimmune, a
company that develops clinical - stage gene therapy solutions.
XRO was developed
based on the
company's experience in helping a major wireless carrier in India launch an LTE network with thousands of
cell sites quickly using hundreds of inexperienced personnel.
First, the interns will gather information about research institutions, academic researchers, and
companies conducting work in adjacent research areas (e.g.
cell therapy
company) who are currently using technologies that are applicable to plant -
based and clean meat research or food technology.
Cuomo and the Business Council made their announcement of the endorsement at a Plug Power, a
company based in a suburb of Albany that manufactures hydrogen fuel
cells.
Silevo is a California -
based company that develops and manufactures silicon solar
cells and modules, with an already established manufacturing plant in China.
A transformative cancer therapy
based on modified immune
cells has lured doctors,
companies, and patients alike, but many are hitting a frustrating roadblock: generating enough of these chimeric antigen receptor (CAR)- T
cells to meet surging demand.
Geron was bigger and better funded than ACT, and it was the first
company to be approved by the US Food and Drug Administration (FDA) to test a therapy in humans
based on embryonic stem (ES)
cells.
One
company, Melbourne, Australia —
based Mesoblast, is already in late - stage clinical trials, treating hundreds of chronic heart failure patients with stem
cell precursors drawn from healthy donors» hip bones.
A prototype device built by nScrypt, a
company in Orlando, Florida, deposits one - hundredth - of - an - inch - thick dollops of lab - cultured
cells onto a layer of gel -
based paper invented at the University of Utah.
Another
company, Belgium -
based TiGenix, hopes to attack scar tissue before it forms by treating patients with a mixture of heart stem
cells within seven days of a heart attack.
The cnidocysts» brutal efficiency served as inspiration for the Israel -
based drug
company NanoCyte, which hopes to harness the anemone's stinging
cells to create a unique drug for diabetics.
The immediate payoff was a commercialization deal in age - related macular degeneration in which Pfizer became the first big pharma
company to make a move into the use of embryonic stem
cells as the
basis for a tissue regeneration therapy.
Israel -
based company, Emefcy, named as a play on the acronym for microbial fuel
cell (MFC), starts with the same principle as most wastewater treatment — water is aerated so bacteria in the liquid break down organic material in a closed series of containers known as a bioreactor.
Davy and Loo have started a new
company, called Andluca Technologies,
based on the technology described in the paper, and are already exploring other applications for the transparent solar
cells.
Another partner in the research was Spectrolab, a US -
based company that provided some of the
cells used in the project.
A
company called Clontech — also
based in Palo Alto — makes virally derived vectors that carry the gene for GFP into
cells.
The Kyoto -
based company Kyosemi has developed a power - harvesting solar
cell that imitates the way that trees collect sunlight from various angles with their leaves.
The telecommunications
company is already running a pilot project in Nuremberg to investigate the extent to which air pollution can be calculated on the
basis of
cell phone data.
Two Dutch scientists working for the biotechnology
company GenPharm International,
based in California, received a patent for a transgenic mouse which is deficient in T
cells and is used to study immune disorders.
And Beijing -
based Wu Stem
Cells will probably do likewise for the same reason, says
company director Cheng Bo.
(That's right — a
company built on chips
based on silicon is trying to get the world to move away from using it in solar
cells.)
The DKFZ researchers conducted this study in collaboration with Epiontis, a Berlin -
based company that specializes in the epigenetic tests that were used to determine the ratio of the various T
cell populations.
This particular type of
cell -
based HTS assay is used by many of the fast - track biotechs and pharmaceutical
companies, and they take good care of their people.
Elsewhere in the United Kingdom, researchers at the University of Sheffield and Roslin
Cells, a
company based in Edinburgh, are also establishing clinical - grade lines.
A U.S. -
based company has received permission to start Europe's first clinical trial involving human embryonic stem (hES)
cells.
In Germany, for example, the Munich -
based biotech
company apceth has already treated patients» gastrointestinal cancer with stem
cells harvested from their own bone marrow and modified to convert a prodrug called ganciclovir.
So Waseem Qasim at University College London created UCART19
cells with help from Paris -
based biopharmaceutical
company Cellectis instead.
Abnormal levels of the proteins may be useful biomarkers that could help us study early treatments to limit or reverse the damage to brain
cells and even prevent the development of the full - blown disease,» said study author Edward Goetzl, MD, a Professor of Medicine with the University of California, San Francisco, a researcher at the National Institute on Aging, and a scientist of NanoSomiX, Inc., a California -
based biotechnology
company that provided a grant for method development for the study.
Ben Shepherd and colleagues at Organovo, a bioengineering
company based in San Diego, California, used a 3D printer loaded with human
cells to build a functional «mini-liver».
Cynata Therapeutics Limited is an Australian clinical - stage stem
cell and regenerative medicine
company developing therapies
based on its proprietary Cymerus ™ stem
cell technology platform.
The Monash BDI researchers worked in collaboration with Canadian -
based company Kinexus, and used an antibody microarray to simultaneously investigate hundreds of factors involved in
cell signalling that were modulated by HCV replication, including human protein kinases.
The multidisciplinary Southampton team, led by Dr Jessica Teeling, and in collaboration with Lundbeck (a multinational pharmaceutical
company based in Denmark), engineered three antibodies to change the way they engage
cells in the immune system.
Vancouver -
based Stemcell Technologies is one
company that has specialized in stem
cell media and reagents for over 15 years, and it's perfectly happy continuing to do just that, says
company president and CEO Allen Eaves.
Ed Field currently is the Chief Operating Officer of Cytomedix, Inc. (OTCBB: CMXI), a US -
based company that is developing and commercializing autologous regenerative biotherapies that promote healing by harnessing the innate regenerative capacity of platelets and adult stem
cells.
In the longer term, Revive aims to nucleate an even larger scale effort that will bring together an expanding number leading scientists, clinicians and biotechnology
companies into a national Consortium for stem
cell -
based regenerative medicine and drug screening.
CDI is currently supplying embryonic stem
cell - derived heart
cells to California -
based Roche and other pharmaceutical
companies for drug screening, and hopes to create other
cell types in the future.
Asterias Biotherapeutics, Inc. is a biotechnology
company dedicated to developing
cell -
based therapeutics to treat neurological conditions associated with de-myelination and cellular immunotherapies to treat cancer.
Company's biomaterial -
based micro-sized compound Regenerods able to attract and stimulate growth of tissue resident stem
cells.
The
company's proprietary
cell therapy programs are
based on its immunotherapy and pluripotent stem
cell platform technologies.
Advanced
Cell Technology, a Santa Monica -
based biotechnology
company, is seeking FDA approval to use such derived
cells to treat Stargardt's macular dystrophy, after studies in rats showed that the
cells could restore vision.
Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with the
company EV Group (EVG) have developed a new silicon -
based multi-junction solar
cell, which can convert exactly one - third of the incident sunlight into useful electricity.
The
Company's lead product is
based on the production of pancreatic progenitors derived from human pluripotent stem
cells.